Biotech | June 15, 2022
ProBioGen and ValenzaBio enter second service agreement
The new program includes upstream and downstream process development and large-scale GMP production.
The new program includes upstream and downstream process development and large-scale GMP production.
Cantourage introduces second Clever Leaves medical cannabis product to the German market
This MoU will further strengthen relations between India and the USA within the framework of international scientific and technological cooperation in fields of mutual interest.
Norliqva was approved by the FDA on February 24, 2022 and is now available through normal retail distribution.
Evrysdi has proven efficacy in babies, children and adults with more than 5,000 patients treated to date
By 2025, the company plans to achieve carbon and water neutrality, zero-waste to landfill, anti-microbial resistance stewardship and green chemistry
Lonza to expand inhalation services by adding capabilities at its Tampa (US) site as part of its continued focus on providing bioavailability enhancement series for global customers
Includes thermostabilized Ebola vaccines
According to IQVIA sales data for the 12-month period ending March 2022, the Zytiga tablets, 500 mg market achieved annual sales of approximately US $ 260.2 million
The drug will be available in 600 hospitals and 105 DTPs
Subscribe To Our Newsletter & Stay Updated
